Research Partners

Amprion values its research partners for their commitment and dedication to science. We stand united on a single mission–finding cures for brain diseases.

We’re known by the company we keep. These research partners joined Amprion on the path of making scientific breakthroughs in neurodegenerative diseases.

National Institute of Neurological Disorders
and Stroke (NIH)

National Institute of Aging

National Institutes of Health

Alzheimer’s Drug Discovery Foundation (ADDF)


Amprion has some important news we need to share with you!

To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.

Old self-pay price: $1500.00. New self-pay price: $995.00

Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process

CPT/PLA – The SYNTap® test has been issued a dedicated PLA code to be used when billing: 0393U
We have applied to be a medicare provider and will soon be able to courtesy bill Medicare for your patients.